A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias

Neurology

Volumn 55, Issue 7, 2000, Pages 964-971

  Gilron, I ^a   Booher, S L ^a   Rowan, J S ^a   Smoller, B ^a   Max, Mitchell B ^a,b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTROMETHORPHAN; KETAMINE; LORAZEPAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; FACE PAIN; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRIGEMINUS NEURALGIA;

EID: 0034633757     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.7.964     Document Type: Article

References (44)

1. Neuropathic pain: Aetiology, symptoms, mechanisms, and management
2. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy
3. Dextrorphan relieves neuropathic heatevoked hyperalgesia in the rat
4. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia
5. Response of chronic neuropathic pain syndromes to ketamine: A preliminary study
6. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation
7. Relief of post herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: A double-blind, crossover comparison with morphine and placebo
8. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post herpetic neuralgia
9. Intravenous infusion of the NMDA antagonist, ketamine, in chronic post-traumatic pain with allodynia: A double-blind comparison to alfentanil and placebo
10. A double-blind randomized controlled trial of dextromethorphan versus memantine versus active placebo in patients with painful diabetic neuropathy and post-herpetic neuralgia
11. The combination of oral morphine and ketamine improves pian relief in postherpetic neuralgia compared with morphine or ketamine alone. A randomized, double blind, placebo-controlled crossover comparison
12. Concerning the cause of trigeminal neuralgia
13. The pathology of trigeminal neuralgia. Electron microscopic studies
14. Pathophysiology of trigeminal neuralgia
15. The mechanism of the pain in trigeminal neuralgia
16. Idiopathic trigeminal neuralgia: Sensory features and pain mechanisms
17. Contribution of central neuroplasticity to pathological pain: Review of clinical and experimental evidence
18. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects
19. The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man
20. Anesthesia dolorosa and the trigeminal caudal nucleus DREZ operation
21. Suppression of autotomy by N-methyl-D-aspartate receptor antagonist (MK-801) in the rat
22. Substantia nigra lesion suppresses the antagonistic effects of N-methyl-D-aspartate receptor antagonist (MK-801) on the autotomy in the rat
23. ICD-10 guide for headaches
24. Orofacial pain
25. Electrophysiological testing of the trigeminofacial system: Aid in the diagnosis of atypical facial pain
26. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain
27. A novel approach to the diagnosis and assessment of symptomatic diabetic neuropathy
28. The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease
29. Neuropathic pain syndromes
30. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia
31. Ratio scales of sensory and affective verbal pain descriptors
32. Validation of combined numericalanalog descriptor scales for rating pain intensity and pain unpleasantness
33. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function
34. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design
35. Statistics in medicine
36. Analgesic effect of capsaicin in idiopathic trigeminal neuralgia
37. The analgesic effect of tocainide in trigeminal neuralgia
38. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood
39. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy
40. Comparison of ketamine and pethidine in experimental and postoperative pain
41. Dose escalation safety and tolerance study of the N-methyl-D-aspartate antagonist dextromethorphan in neurosurgery patients
42. Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist
43. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: Correlation with restricted localisation of NR2B subunit in dorsal horn